Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSCT for SCID without HLA-matched sibling donor
NCT02127892Phase 2Terminated
- Start
- Jan 2007
- Primary completion
- Aug 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hematopoietic stem cells in severe combined immunodeficiency (SCID). Started Jan 2007; status: terminated.
02
Drugs
hematopoietic stem cells
03
Conditions
severe combined immunodeficiency (SCID)
Beyond the preview
Go deeper on NCT02127892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127892.